Health Catalyst (NASDAQ:HCAT) Raised to “Overweight” at KeyCorp

Health Catalyst (NASDAQ:HCAT) was upgraded by equities researchers at KeyCorp from a “sector weight” rating to an “overweight” rating in a research note issued on Wednesday,Briefing.com Automated Import reports. The firm currently has a $9.00 price objective on the stock. KeyCorp’s price target suggests a potential upside of 28.94% from the stock’s previous close.

Other equities research analysts have also recently issued research reports about the stock. Evercore ISI increased their target price on shares of Health Catalyst from $8.00 to $10.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. Stephens raised their price objective on Health Catalyst from $7.00 to $9.00 and gave the stock an “equal weight” rating in a research report on Thursday, November 14th. Royal Bank of Canada upped their target price on Health Catalyst from $8.00 to $9.00 and gave the company a “sector perform” rating in a research report on Thursday, November 7th. Piper Sandler reiterated an “overweight” rating and issued a $12.00 price target (up from $11.00) on shares of Health Catalyst in a research note on Tuesday, November 26th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $16.00 price target on shares of Health Catalyst in a research note on Friday, October 4th. Two equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $11.50.

Health Catalyst Trading Down 5.7 %

HCAT opened at $6.98 on Wednesday. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.32. The firm has a market cap of $424.72 million, a price-to-earnings ratio of -5.17 and a beta of 1.36. Health Catalyst has a 12 month low of $5.42 and a 12 month high of $11.41. The stock has a fifty day moving average price of $7.83 and a 200-day moving average price of $7.52.

Health Catalyst (NASDAQ:HCAT) last announced its earnings results on Wednesday, November 6th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). The firm had revenue of $76.40 million during the quarter, compared to the consensus estimate of $76.27 million. Health Catalyst had a negative return on equity of 7.51% and a negative net margin of 26.20%. The business’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.22) earnings per share. As a group, equities research analysts anticipate that Health Catalyst will post -0.33 earnings per share for the current fiscal year.

Insider Activity at Health Catalyst

In related news, insider Kevin Lee Freeman sold 7,500 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $8.94, for a total transaction of $67,050.00. Following the completion of the transaction, the insider now owns 236,950 shares of the company’s stock, valued at $2,118,333. This trade represents a 3.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Daniel Lesueur sold 5,209 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $7.70, for a total transaction of $40,109.30. Following the transaction, the chief operating officer now owns 129,690 shares of the company’s stock, valued at $998,613. This represents a 3.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 68,342 shares of company stock worth $554,695 over the last quarter. Insiders own 2.50% of the company’s stock.

Hedge Funds Weigh In On Health Catalyst

A number of institutional investors have recently modified their holdings of the stock. Quest Partners LLC purchased a new stake in shares of Health Catalyst in the third quarter worth about $34,000. Quarry LP lifted its holdings in Health Catalyst by 59.4% in the second quarter. Quarry LP now owns 7,002 shares of the company’s stock valued at $45,000 after acquiring an additional 2,610 shares during the period. nVerses Capital LLC purchased a new stake in Health Catalyst in the 3rd quarter worth approximately $59,000. Mackenzie Financial Corp acquired a new stake in shares of Health Catalyst during the 2nd quarter worth approximately $70,000. Finally, Quadrature Capital Ltd purchased a new position in shares of Health Catalyst during the 3rd quarter valued at approximately $84,000. Hedge funds and other institutional investors own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.